INS and Hypoglycemia: Using manual insulin correction doses or temporary basal rates to manage significant hyperglycemia carries an inherent risk of resultant hypoglycemia.7 Appropriate dosing decisions rely on the accuracy of a range of settings, as well as the timing of the corrective insulin dose itself, making dosing decisions a challenging task.7 In contrast “Boost” enables an increase in algorithm-driven insulin delivery adjusted continuously based on sensor glucose values, with the algorithm using parameters based on adaptive learning, rather than pre-defined settings.